Editorial: Sleep disorders in neuromuscular diseases: treatable conditions: the evolving scenario of sleep in neuromuscular disorders.
作者信息
Angelini Corrado Italo, Siciliano Gabriele, Ansevin Carl
机构信息
University of Padua, Padua, Italy.
University of Pisa, Pisa, Tuscany, Italy.
出版信息
Front Neurol. 2024 Jul 11;15:1448486. doi: 10.3389/fneur.2024.1448486. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Sleep disorders in neuromuscular diseases: treatable conditions: the evolving scenario of sleep in neuromuscular disorders.社论：神经肌肉疾病中的睡眠障碍：可治疗的病症：神经肌肉疾病中睡眠情况的演变
Front Neurol. 2024 Jul 11;15:1448486. doi: 10.3389/fneur.2024.1448486. eCollection 2024.
2
The role of sleep in neuromuscular disorders.睡眠在神经肌肉疾病中的作用。
Front Neurol. 2023 Jun 29;14:1195302. doi: 10.3389/fneur.2023.1195302. eCollection 2023.
3
Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.夏科-马里-图斯病的肺功能、睡眠及上呼吸道障碍
Lung. 2007 Jan-Feb;185(1):1-7. doi: 10.1007/s00408-006-0053-9. Epub 2007 Feb 9.
4
Intraoral Neuromuscular Stimulation Device and Rapid Eye Movement-Dependent Obstructive Sleep Apnea.口腔内神经肌肉刺激装置与快速眼动相关阻塞性睡眠呼吸暂停
Cureus. 2022 Jul 28;14(7):e27418. doi: 10.7759/cureus.27418. eCollection 2022 Jul.
5
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.神经肌肉疾病进展的MRI生物标志物评估：一项前瞻性观察性队列研究。
Lancet Neurol. 2016 Jan;15(1):65-77. doi: 10.1016/S1474-4422(15)00242-2. Epub 2015 Nov 6.
6
Improvement of Neuropathy Symptoms With Treatment of Obstructive Sleep Apnea in a Patient With Charcot-Marie-Tooth Disease.治疗 Charcot-Marie-Tooth 病患者的阻塞性睡眠呼吸暂停可改善神经病变症状。
J Clin Sleep Med. 2018 Feb 15;14(2):289-291. doi: 10.5664/jcsm.6956.
7
Intermittent positive airway pressure by nasal mask as a treatment for respiratory insufficiency in a patient with Charcot-Marie-Tooth disease.经鼻面罩间歇性气道正压通气治疗夏科-马里-图思病患者的呼吸功能不全
Acta Clin Belg. 2006 Jul-Aug;61(4):176-81. doi: 10.1179/acb.2006.030.
8
Rehabilitation interventions for foot drop in neuromuscular disease.神经肌肉疾病中足下垂的康复干预措施。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD003908. doi: 10.1002/14651858.CD003908.pub3.
9
Sleep disorders and neuromuscular disease.睡眠障碍与神经肌肉疾病。
Semin Neurol. 2005 Mar;25(1):33-8. doi: 10.1055/s-2005-867071.
10
Sleep pattern in Charcot-Marie-Tooth disease type 2: report of family case series.2型遗传性运动感觉神经病的睡眠模式：家族病例系列报告
J Clin Sleep Med. 2015 Mar 15;11(3):205-11. doi: 10.5664/jcsm.4526.
本文引用的文献
1
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.每日一次利司扑兰治疗 2 型和非卧床 3 型脊髓性肌萎缩症（SUNFISH 研究 2 部分）的安全性和有效性：一项 3 期、双盲、随机、安慰剂对照试验。
Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
2
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1.1型强直性肌营养不良症临床试验疗效的结局指标：中枢神经系统受累情况
Front Neurol. 2020 Oct 7;11:624. doi: 10.3389/fneur.2020.00624. eCollection 2020.
3
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.依库珠单抗治疗晚发性脊髓性肌萎缩症的疗效观察：一项随机、双盲、安慰剂对照 3 期试验
N Engl J Med. 2018 Feb 15;378(7):625-635. doi: 10.1056/NEJMoa1710504.
Zotero 插件